U.S. Markets closed

Abeona Therapeutics Inc. (ABEO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.5750-0.0335 (-5.51%)
At close: 04:00PM EST
0.6000 +0.03 (+4.35%)
After hours: 06:20PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.6085
Bid0.5600 x 800
Ask0.6000 x 1200
Day's Range0.5605 - 0.6143
52 Week Range0.5600 - 3.7900
Avg. Volume793,971
Market Cap57.438M
Beta (5Y Monthly)1.52
PE Ratio (TTM)N/A
EPS (TTM)-0.5590
Earnings DateNov 08, 2021 - Nov 12, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.00
  • InvestorPlace

    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

    Good morning, trader! We’re gearing up for another busy day of trading with the biggest pre-market stock movers for Thursday! Source: ventdusud / News moving stocks today include earnings reports, social media chatter, Omicron, and more. Let’s get into that news below!InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pre-Market Stock Movers: 10 Top Gainers Digital World Acquisition (NASDAQ:DWAC) stock is soaring more than 21% on reports the SPAC plans to raise $1 bi

  • Zacks

    Down 15.2% in 4 Weeks, Here's Why Abeona Therapeutics (ABEO) Looks Ripe for a Turnaround

    Abeona Therapeutics (ABEO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

  • GlobeNewswire

    Abeona Therapeutics Announces Support of EB Research Partnership's Venture Into Cures Event to Raise Awareness for Education and Research of Epidermolysis Bullosa

    NEW YORK and CLEVELAND, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced its sponsorship of the second annual Venture Into Cures, a virtual event supporting EB Research Partnership's mission to find a cure for epidermolysis bullosa (EB). The event will take place virtually on November 18, 2021 at 8:00 p.m. ET/ 5:00 p.m. PT. The one-hour show will feature inspiring stories about individuals and families